Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter from Jim Otteson to the ITC Chairman from the ITC
The NDoC issued its claim construction first and the ALJ at the ITC did not follow the NDoC's claim construction. Nothing is binding. The appelate court (the court above the NDoC and ITC) controls both venues but as has been discussed many times so far, the appelate court would take too long to overturn an adverse ITC final decision. I suggest calling the company to confirm as much.
Share
New Message
Please login to post a reply